Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.

 
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.

Pharmaceutical Executive Europe  E-News
 
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecdigi
 
Survey
We asked over 40 pharma leaders, who should drive universal anticounterfeiting solutions?

Pharma 54%
Regulators 38%
Vendors 8%

Talk to us:
editor@pharmexeceurope.com

Advertise with us: jgray@advanstar.com


4 October, 2011
In this Issue
Get Back in the Box! Time to Temper Radical Thinking with Wisdom
In pharma, crisis and complacency have peacefully coexisted for decades. Neither characteristic appears to have had the upper hand, but lately, the pendulum is swinging to a new consensus: companies must embrace a radical, innovatively "disruptive" mindset to avoid being declared irrelevant in a game-changing transfer of market power to clinicians and customers... More...
Lilly: Taking In-Licensing to the Next Level
It’s no secret that large pharmaceutical companies are shedding internal R&D staff, and turning towards in-licensing of promising molecules to bolster their early-stage pipelines. Eli Lilly, however, instead of looking entirely at late-stage chemical entities, has expanded a programme that looks externally to mine the scientific community for promising preclinical leads...
More...
Pharma Hesistancy Over Germany's New Pricing Law
Ed Schoonveld and Johann Meyer-Christian report on how Germany's new AMNOG-based system could lead to a halt on drug launches in the country...
More...
Clinical Trials in Europe: Your View
This short, anonymous SAT-EU study aims to understand the industry's trial site selection criteria for II-III multi-centric studies in Europe, to survey industry's current perceptions of the European and Italian trial environment, and to rank potential improvements. Click here to take the survey... More...
Also in this issue…
Ukraine Tackles IPR Problem
Latest Pharma Appointments
Upcoming Pharma Event: BioBusiness (London, January 2012)

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail

at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK